Regulation of cyclin T1 expression and function by an alternative splice variant that skips exon 7 and contains a premature termination codon

Gene

Volumn 505, Issue 1, 2012, Pages 1-8

  Urano, Emiko ^a   Miyauchi, Kosuke ^a,b   Ichikawa, Reiko ^a   Futahashi, Yuko ^a   Komano, Jun ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Alternative splicing; Cyclin T1 (CCNT1); Exon skipping; Human immunodeficiency virus type 1 (HIV 1); Nonsense mediated mRNA decay (NMD); Premature termination codon (PTC)

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; CYCLOHEXIMIDE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL PROLIFERATION; CODON; CONTROLLED STUDY; EXON; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUES;

ALTERNATIVE SPLICING; ANDROSTADIENES; CELL LINE; CODON, TERMINATOR; CYCLIN T; CYCLIN-DEPENDENT KINASE 9; CYCLOHEXIMIDE; EXONS; FEMALE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PROTEIN KINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863876697     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.06.006     Document Type: Article

References (45)

1. Barboric M., et al. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res. 2007, 35:2003-2012.
2. Barboric M., Lenasi T., Chen H., Johansen E.B., Guo S., Peterlin B.M. 7SK snRNP/P-TEFb couples transcription elongation with alternative splicing and is essential for vertebrate development. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7798-7803. (Epub 2009 Apr 27).
3. Baumli S., et al. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 2008, 27:1907-1918. (Epub 2008 Jun 19).
4. Bres V., Yoh S.M., Jones K.A. The multi-tasking P-TEFb complex. Curr. Opin. Cell Biol. 2008, 20:334-340. Epub 2008 May 29.
5. Bres V., Yoshida T., Pickle L., Jones K.A. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol. Cell 2009, 36:75-87.
6. Byers S.A., Price J.P., Cooper J.J., Li Q., Price D.H. HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK. J. Biol. Chem. 2005, 280:16360-16367. (Epub 2005 Feb 14).
7. Carter M.S., et al. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J. Biol. Chem. 1995, 270:28995-29003.
8. De Falco M., De Luca A. Involvement of cdks and cyclins in muscle differentiation. Eur. J. Histochem. 2006, 50:19-23.
9. De Falco G., et al. Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors. Cancer Biol. Ther. 2005, 4:277-281. (Epub 2005 Mar 20).
10. De Falco G., et al. Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells. J. Cell. Physiol. 2008, 215:276-282.
11. Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
12. Duncan A.W., et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010, 467:707-710. (Epub 2010 Sep 22).
13. Elagib K.E., et al. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation. Blood 2008, 112:4884-4894. (Epub 2008 Sep 9).
14. Garriga J., Grana X. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 2004, 337:15-23.
15. Garriga J., Peng J., Parreno M., Price D.H., Henderson E.E., Grana X. Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene 1998, 17:3093-3102.
16. Haaland R.E., Herrmann C.H., Rice A.P. Increased association of 7SK snRNA with Tat cofactor P-TEFb following activation of peripheral blood lymphocytes. AIDS 2003, 17:2429-2436.
17. Herrmann C.H., Mancini M.A. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci. 2001, 114:1491-1503.
18. Herrmann C.H., Carroll R.G., Wei P., Jones K.A., Rice A.P. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 1998, 72:9881-9888.
19. Ivanov D., Kwak Y.T., Nee E., Guo J., Garcia-Martinez L.F., Gaynor R.B. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J. Mol. Biol. 1999, 288:41-56.
20. Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 2005, 19:523-534.
21. Komano J., Miyauchi K., Matsuda Z., Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol. Biol. Cell 2004, 15:5197-5207.
22. Leucci E., et al. The role of the Cdk9/Cyclin T1 complex in T cell differentiation. J. Cell. Physiol. 2007, 212:411-415.
23. Lewis B.P., Green R.E., Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:189-192. (Epub 2002 Dec 26).
24. Liou L.Y., Herrmann C.H., Rice A.P. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J. Virol. 2002, 76:10579-10587.
25. Liou L.Y., Haaland R.E., Herrmann C.H., Rice A.P. Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages. J. Leukoc. Biol. 2006, 79:388-396. (Epub 2005 Dec 5).
26. Marshall R.M., Grana X. Mechanisms controlling CDK9 activity. Front. Biosci. 2006, 11:2598-2613.
27. Marshall R.M., Salerno D., Garriga J., Grana X. Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. J. Immunol. 2005, 175:6402-6411.
28. Nguyen V.T., Kiss T., Michels A.A., Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 2001, 414:322-325.
29. Pal M., Ishigaki Y., Nagy E., Maquat L.E. Evidence that phosphorylation of human Upfl protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway. RNA 2001, 7:5-15.
30. Peterlin B.M., Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 2006, 23:297-305.
31. Pirngruber J., Shchebet A., Johnsen S.A. Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing. Cell Cycle 2009, 8:3636-3642. (Epub 2009 Nov 24).
32. Rechter S., et al. Cyclin-dependent kinases phosphorylate the cytomegalovirus RNA export protein pUL69 and modulate its nuclear localization and activity. J. Biol. Chem. 2009, 284:8605-8613. (Epub 2009 Jan 29).
33. Sawicka K., Bushell M., Spriggs K.A., Willis A.E. Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans. 2008, 36:641-647.
34. Shimizu S., et al. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex. AIDS 2007, 21:575-582.
35. Spellman R., et al. Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans. 2005, 33:457-460.
36. Stalder L., Muhlemann O. The meaning of nonsense. Trends Cell Biol. 2008, 18:315-321. (Epub 2008 Jun 2).
37. Sung T.L., Rice A.P. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Retrovirology 2006, 3:66.
38. Sung T.L., Rice A.P. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 2009, 5:e1000263. (Epub 2009 Jan 16).
39. Urano E., et al. Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription. AIDS 2008, 22:1081-1083.
40. Urano E., Ichikawa R., Morikawa Y., Yoshida T., Koyanagi Y., Komano J. T cell-based functional cDNA library screening identified SEC14-like 1a carboxy-terminal domain as a negative regulator of human immunodeficiency virus replication. Vaccine 2010, 28:B68-B74.
41. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462.
42. Yamashita A., Ohnishi T., Kashima I., Taya Y., Ohno S. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 2001, 15:2215-2228.
43. Yang Z., Zhu Q., Luo K., Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 2001, 414:317-322.
44. Yang Z., He N., Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol. Cell. Biol. 2008, 28:967-976. (Epub 2007 Nov 26).
45. Zhou Q., Yik J.H. The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol. Mol. Biol. Rev. 2006, 70:646-659.